Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Some psychiatric drugs can cause severe hair loss, especially valproic acid, and it's more likely in women or those with thyroid issues or past hair loss.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Terbinafine can cause hair loss.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

Topical calcipotriol successfully treated hair loss in three patients with Alopecia Totalis.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Chemicals and stem cells combined have advanced regenerative medicine with few safety concerns, focusing on improving techniques and treatment effectiveness.

Psoriasis treatments range from topical creams to systemic medications with serious side effects, and while treatments can manage symptoms, there is no cure.

Cyclosporin doesn't stop hair loss.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The Rotterdam Study aims to understand various diseases in older adults.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Doctors need to be better prepared to assess and treat obesity in patients.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

HIV can cause unusual and severe skin problems that are hard to treat.

PRP injections effectively treat hair loss, with positive results in both monthly and every three months treatments.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.